Expertise: Resistant H. Pylori
Resistant Helicobacter pylori - How do we eradicate it?
Standard first-line treatment for H. pylori infection is marketed throughout Australia.
Unfortunately once a patient has been treated using a standard first-line treatment, but fails to
eradicate the infection, the H. pylori remaining can become resistant to a number of the antibiotics used.
As such it is imperative that the patient is treated with different antibiotics to reduce the likelihood of
creating a "super-resistant" infection.
At the Centre for Digestive Diseases we have developed a second-line treatment which we have
seen a success rate of greater that 96% (published data), compared to re-treating with the same or similar
first-line treatment which have a low success rate.
Our second-line treatments, which are adjusted to suit each patient based on the number
and type of previous treatment, can include the following medications: Rifabutin, Bismuth subcitrate,
Furazolidone, Pronase, Lactoferrin, and Nitazoxanide.
Back
Home
|
